article thumbnail

Galapagos enters deal to boost decentralised CAR-T therapy production

Pharmaceutical Technology

Galapagos has signed a partnership with Blood Centers of America to expedite decentralised production of CAR-T cell therapies across the US.

article thumbnail

Export of Ayush and herbal products registers 1.65% growth in first 10 months

AuroBlog - Aurous Healthcare Clinical Trials blog

Exports of Ayush (Ayurveda, Yoga, Naturopathy, Unani, Siddha, Sowa-Rigpa and Homoeopathy) drugs and herbal products from the country have reported 1.65 per cent growth during the first ten months of the current fiscal year. The growth in the month of January stood at 14.54

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Ayush and herbal products exports register 3.6% growth in 2023-24

AuroBlog - Aurous Healthcare Clinical Trials blog

India’s export of Ayush and herbal products has reported a growth of 3.6 per cent during the fiscal year 2023-24, at $651.17 million as compared to the same period of previous year, registering a below-five per cent growth for the second consecutive year. The country reported exports of 10.63

article thumbnail

Large Review Finds CBD Products Don’t Relieve Chronic Pain After All

AuroBlog - Aurous Healthcare Clinical Trials blog

Evidence does not support the use of cannabidiol (CBD) products as a treatment for chronic pain, a new review found.

article thumbnail

Making the Case for Case Management for Cell and Gene Therapies

As demand for advanced therapies increases, so does the need for more specialized supply chain support, as these products have strict transportation and handling requirements.

article thumbnail

Cipla and Glenmark initiate recall of certain products in the US

Pharmaceutical Technology

Cipla and Glenmark Pharmaceuticals are recalling specific products from the US market due to distinct manufacturing issues.

article thumbnail

Bristol Myers taps startup to boost CAR-T production

Bio Pharma Dive

A partnership with Cellares, worth up to $380 million, is meant to help Bristol Myers speed and scale manufacture of the complex cellular treatments.

article thumbnail

Commercial Drug Sourcing for Clinical Trials

Sponsors can face a number of challenges when trying to obtain these critical supplies for their studies, including addressing product lead times, availability, expiry limitations, safety and cost, among others.

article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight.